Samsung Medical Center
| Corea del Sud | Turchia | Austria | |
| Fisioterapia | da $100 | da $50 | da $600 |
| Terapia con cellule staminali per spondilite anchilosante | - | da $7,000 | da $20,000 |
| Terapia biologica | - | da $5,500 | da $20,000 |
Ahn Tae Hoon, MD, PhD, is a cardiology specialist and Director of the Cardiovascular Center at Naeun Hospital. He has expertise in coronary artery disease (angina, myocardial infarction), hypertension, valvular heart disease, heart failure, and cardiovascular interventional procedures.
He earned his PhD in Medicine from Korea University College of Medicine. He completed an Internal Medicine residency at Korea University Guro Hospital and a Cardiology fellowship at Korea University Hyehwa Hospital. He also completed clinical training at the Montreal Heart Institute.
He previously served as Professor and Director of the Cardiovascular Center at Gachon University Gil Medical Center. He was a Clinical Professor at Korea University Anam Hospital and at Chung-Ang University Gwangmyeong Hospital. His leadership roles include President of KSIC, KCCC, KVIS, and KSC. He also served as Treasurer of KSC and as Organizing Committee Chair of ENCORE SEOUL.
Yang Young-Joon, MD, is an orthopedic surgeon and Director of the Joint Center. He treats knee and shoulder disorders, sports injuries, foot and ankle problems, carpal tunnel syndrome, and fractures and other trauma. His practice also includes joint replacement, arthroscopic surgery, pediatric orthopedics, hip disorders, hand and foot microsurgery, hand numbness, diabetic foot, hallux valgus, and gout.
He completed his orthopedic surgery residency at Catholic Central Medical Center and an orthopedic surgery fellowship at St. Paul’s Hospital at Catholic Central Medical Center. He is a regular member of the Korean Arthroscopy, Knee, and Shoulder Societies and serves as Director of the Orthopedic Center at Naeun Hospital.
Dr. Jang Hyo Kim is an orthopedic surgeon focused on joint preservation and complex reconstruction. He specializes in arthroscopy of the shoulder, knee, ankle, elbow, and wrist. He performs joint replacement of the shoulder, knee, ankle, elbow, and hip. His spine work includes cervical and lumbar instrumentation and fusion. He also performs discectomy, laminectomy, neuroplasty, and vertebroplasty. His practice includes fracture care and muscle and ligament repair.
He is an Adjunct Professor at Kyung Hee University. He serves as Director of the Joint Center at Very Good Hospital. He previously served as chief or director at Yeonggwang General, Songjeong Sarang, Sewoori–Daejeon, Seoul Welfare, and The Barun hospitals. He was an advisory member of the Gwangju–Jeonnam Workers’ Compensation Board. He is a full member of the Korean Orthopaedic Association (KOA) and the Korean Societies of Arthroscopy, Knee, Sports Medicine, Hip, Pain, and Obesity. He holds TPI therapy certification. He completed an Ilizarov fellowship in Kurgan, Russia. He also completed training in shoulder arthroscopy.
Il medico è un neurologo di spicco in Corea del Sud, specializzato nel trattamento dell'epilessia. Attualmente, il medico è a capo del Dipartimento di Neurologia presso l'ospedale Yonsei Severance.<\/p>
Il medico si è laureato presso il College of Medicine dell'Università Yonsei ed è un membro attivo di diverse organizzazioni professionali, tra cui la Società Coreana di Epilessia, l'Associazione Neurologica Coreana e l'Associazione Medica Coreana.<\/p>
South Korea National Health Insurance covers biologics for ankylosing spondylitis under the Rare Intractable Disease program. Patients typically pay only 10% of treatment costs. Coverage requires specific clinical criteria like active sacroiliitis on imaging and failure of conventional therapies after 3 months.
Bookimed Expert Insight: Patients should prioritize university hospitals like Severance or Asan Medical Center for initial biologic approval. These academic centers manage high patient volumes and have streamlined systems for RID registration. Major facilities also utilize digital systems like BESTcare to track treatment history and prevent documentation errors during appeals.
Patient Consensus: Patients note that documenting every medication failure is vital for insurance approval. Many find that while initial drug costs seem high, the 10% co-pay cap makes long-term biologic therapy affordable.